ArticleHIV medicine2026
Sex differences in cardiovascular disease and associated factors in people living with HIV: Evidence from All of Us program.
Article in HIV medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy.Immunity & ageing : I & A · 2026Article
- Determinants of left ventricular hypertrophy in a cohort attending a medical clinic: A comparative analysis stratified by sex.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPeople living with HIV (PLWH) face a higher risk of cardiovascular disease (CVD), with significant sex differences in outcomes. However, it is unclear whether these differences are driven by distinct risk factor profiles or by a differential impact of shared risk factors. This study aimed to identify factors associated with CVD among PLWH and to specifically assess for effect modification by sex using a large, diverse nationwide database.
methodsWe utilized data from the All of Us Research Program (AoU). The primary outcome was a composite of coronary artery disease or stroke. We used multivariable logistic regression to identify factors associated with CVD in the overall cohort. To assess for effect modification, we introduced interaction terms between sex and key covariates. Subsequently, sex-stratified analyses were performed to explore these differences.
resultsAmong 6464 PLWH (4608 men and 1856 women), women had a higher prevalence of CVD than men (24.8% vs. 21.9%, p = 0.011). We identified significant interaction effects between sex and several key risk factors, including hypertension, unemployment and hyperlipidaemia (p < 0.05 for all). In stratified analyses comparing women to men within these risk groups, the association of hypertension with CVD was substantially stronger in women than in men (adjusted odds ratio [aOR] = 4.928, 95% CI: 2.827-8.586). Similarly, the effects of unemployment and hyperlipidaemia on CVD were more pronounced in women. In fully stratified models, a detectable viral load was a significant risk factor for CVD only among men (aOR = 1.524, 95% CI: 1.130-2.049).
conclusionsWhile many traditional and HIV-specific CVD risk factors are shared between men and women living with HIV (WLWH), our findings reveal that the magnitude of their effect is not uniform. The impact of key risk factors, particularly hypertension, is substantially greater in women, suggesting a heightened vulnerability to these exposures. These findings underscore the critical need for sex-specific risk assessments and aggressively tailored prevention strategies for PLWH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.